Jayson Bedford
Stock Analyst at Raymond James
(3.89)
# 649
Out of 4,983 analysts
318
Total ratings
56.81%
Success rate
7.56%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $99.12 | +14.00% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $130.36 | +38.08% | 21 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $82.69 | +23.35% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $76.55 | +33.25% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $98.98 | +25.28% | 26 | Jul 24, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $142 → $141 | $132.76 | +6.21% | 29 | Jul 18, 2025 | |
| PODD Insulet | Maintains: Outperform | $328 → $360 | $332.13 | +8.39% | 27 | May 27, 2025 | |
| MASI Masimo | Maintains: Outperform | $204 → $185 | $143.00 | +29.37% | 7 | May 7, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $162 → $164 | $176.46 | -7.06% | 23 | Apr 16, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $560 → $688 | $434.50 | +58.34% | 8 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $186.21 | +45.00% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $16.73 | -22.30% | 1 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $10.48 | -4.58% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $125.82 | +115.39% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $16.89 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $12.43 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $75.09 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $23.87 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $94.19 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $0.45 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $63.33 | +35.80% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.41 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $14.83 | - | 3 | Jan 2, 2018 |
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $99.12
Upside: +14.00%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $130.36
Upside: +38.08%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $82.69
Upside: +23.35%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $76.55
Upside: +33.25%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $98.98
Upside: +25.28%
Abbott Laboratories
Jul 18, 2025
Maintains: Outperform
Price Target: $142 → $141
Current: $132.76
Upside: +6.21%
Insulet
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $332.13
Upside: +8.39%
Masimo
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $143.00
Upside: +29.37%
Johnson & Johnson
Apr 16, 2025
Maintains: Outperform
Price Target: $162 → $164
Current: $176.46
Upside: -7.06%
Intuitive Surgical
Jan 24, 2025
Maintains: Outperform
Price Target: $560 → $688
Current: $434.50
Upside: +58.34%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $186.21
Upside: +45.00%
Jul 1, 2024
Initiates: Outperform
Price Target: $13
Current: $16.73
Upside: -22.30%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $10.48
Upside: -4.58%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $125.82
Upside: +115.39%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $16.89
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $12.43
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $75.09
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $23.87
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $94.19
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $0.45
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $63.33
Upside: +35.80%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $1.41
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $14.83
Upside: -